Dubai, United Arab Emirates, October 3, 2024 — Huawei has announced a collaboration with the Dubai Health Innovation and Digital Health team to conduct a validation study on ambulatory blood pressure monitoring technology. The study aims to assess the effectiveness of the ambulatory blood pressure monitoring capabilities using Huawei’s wrist-based wearables.

Born from a decade of research and development in blood pressure technology, Huawei’s latest advancements represent significant progress in wrist-based monitoring. The collaboration aims to assess the effectiveness of this technology in providing accurate and convenient blood pressure measurements.